To corroborate the assumption that the SCG3 expression detected in the blood of SCLC patients is derived exclusively from tumor cells, we optimized a noninvasive methodology using real-time quantitative PCR to detect SCG3 transcript traces in the peripheral blood of SCLC patients. This evidence concerns the gene SCG3 and neoplasm.